Benjamin J. Zeskind - Feb 28, 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
PRESIDENT AND CEO, Director, 10%+ Owner
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Benjamin J. Zeskind
Stock symbol
IMRX
Transactions as of
Feb 28, 2022
Transactions value $
$6,020
Form type
4
Date filed
3/1/2022, 04:19 PM
Previous filing
Feb 14, 2022
Next filing
Mar 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Options Exercise $6.02K +2K +0.09% $3.01 2.25M Feb 28, 2022 Direct
holding IMRX Class A Common Stock 895K Feb 28, 2022 See Foonote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Options Exercise $0 -2K -0.95% $0.00 208K Feb 28, 2022 Class A Common Stock 2K $3.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.
F2 The option has fully vested and is currently exercisable.